XML 11 R2.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 25,731,010 $ 28,094,936
Prepaid assets and other current assets 859,064 1,092,462
Total assets 26,590,074 29,187,398
Current liabilities:    
Accounts payable 1,204,951 410,638
Total current liabilities 1,204,951 410,638
Accrued research and development expense (see Note 5) 1,132,013
Total liabilities 1,204,951 1,542,651
Stockholders' equity (deficit):    
Common stock; $0.001 par value, 45,000,000 shares authorized; 18,671,658 and 18,450,992 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 18,672 18,451
Additional paid-in capital 44,896,346 43,338,710
Accumulated other comprehensive loss (20,283)
Accumulated deficit (19,509,612) (15,712,414)
Total stockholders' equity 25,385,123 27,644,747
Total liabilities and stockholders' equity $ 26,590,074 $ 29,187,398